AUA 2013 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer (mCRPC) patients prior to receiving sipuleucel-T: Data from PROCEED

SAN DIEGO, CA USA ( - Presented by Matthew R. Cooperberg, MD,1 Oliver Sartor, MD,2 Christopher Pieczonka, MD,3 Raoul S. Concepcion, MD, FACS,4 Vahan Kassabian, MD,5 Ronald Tutrone, MD, FACS, CPI,6 James Bailen, MD,7 Neal Shore, MD, FACS,8 Lawrence Karsh, MD, FACS,9 Bernard Hertzman, MD,10 David Penson, MD, MPH,11 Candice Mccoy, MD,12 Andrew Sandler, MD,12 Robert Tyler, PhD,12 James Whitmore, PhD,12 and Celestia S. Higano, MD13 at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

Treatment Practice Patterns in mCRPC Patients Prior to Receiving sip-T thumb

1University of California, San Francisco, San Francisco, CA; 2Tulane Cancer Center, New Orleans, LA; 3Associated Medical Professionals, Syracuse, NY; 4Urology Associates, Nashville, TN; 5Georgia Urology, Atlanta, GA; 6Cheasapeake Urology Research Associates, Baltimore, MD; 7Metropolitan Urology, Jeffersonville, IN 8Atlantic Urology Clinics, Myrtle Beach, SC; 9The Urology Center of Colorado, Denver CO; 10The Urology Group, Cincinnati, OH; 11Vanderbilt-Ingram Cancer Center, Nashville, TN; 12Dendreon Corporation, Seattle, WA; 13University of Washington, Seattle, WA

Click HERE to listen to Dr. Cooperberg discuss the poster


View Full AUA 2013 Coverage